Expression of the KIT Protein (CD117) in Primary Cutaneous Mast Cell Tumors of the Dog
Open Access
- 1 November 2004
- journal article
- research article
- Published by SAGE Publications in Journal of Veterinary Diagnostic Investigation
- Vol. 16 (6) , 554-561
Abstract
Thirty-one canine cutaneous masses, diagnosed as mast cell tumors (MCT) by histopathologic analysis, were used to evaluate the immunohistochemical pattern of expression of KIT protein (CD117), a type III tyrosine kinase protein involved in mast cell growth and differentiation. Lesions were graded as I (well differentiated), II (intermediate differentiation), or III (poorly differentiated) according to the following morphologic features: invasiveness, cellularity and cellular morphology, mitotic index, and stromal reaction. Immunohistochemical KIT expression was compared with histologic grade and some histomorphologic features (cell differentiation and nuclear grade) evaluated separately. A possible predictive role of biologic behavior in MCTs for KIT expression was also investigated. Immunohistochemical analysis revealed three different patterns of KIT expression: a cytoplasmic diffuse pattern, a membranous pattern with immunostaining located on the cell surface, and a cytoplasmic perinuclear pattern, where KIT expression was detected in the cytoplasm of the neoplastic mast cells, close to the nucleus. Statistical analysis showed a close relationship between different KIT immunohistochemical patterns and histologic grade (P < 0.00000), cell differentiation (P < 0.00000), and nuclear grade (P < 0.0024). According to Kaplan-Meier–estimated survival curves compared by survival analysis, KIT expression was significantly associated with survival time (P = 0.037) but not cancer-free interval (P = 0.50). Similar to other well-known histomorphological features, KIT expression is a useful parameter of malignancy in cutaneous MCTs. KIT expression also predicted the biological behavior of the tumors in this study.Keywords
This publication has 27 references indexed in Scilit:
- Clustering of Activating Mutations in c-KIT’s Juxtamembrane Coding Region in Canine Mast Cell NeoplasmsJournal of Investigative Dermatology, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Expression of stem cell factor receptor (c-kit) by the malignant mast cells from spontaneous canine mast cell tumoursJournal of Comparative Pathology, 1996
- Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasmNature Genetics, 1996
- Prognosis of Canine Mast Cell Tumors: A Comparison of Three MethodsVeterinary Pathology, 1994
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.Journal of Clinical Investigation, 1993
- Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor.Proceedings of the National Academy of Sciences, 1991
- Nucleolar organiser regions as indicators of post-surgical prognosis in canine spontaneous mast cell tumoursBritish Journal of Cancer, 1989
- Canine Cutaneous Mast Cell Tumor: Morphologic Grading and Survival Time in 83 DogsVeterinary Pathology, 1984
- The prognosis following surgical removal of mastocytomas in dogsJournal of Small Animal Practice, 1973